halofuginone 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| 5553 | 55837-20-2 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
|
Drug dosage:
None
ADMET properties:
None
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| None | FDA |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| MeSH PA | D020533 | Angiogenesis Inhibitors |
| MeSH PA | D000890 | Anti-Infective Agents |
| MeSH PA | D000970 | Antineoplastic Agents |
| MeSH PA | D000977 | Antiparasitic Agents |
| MeSH PA | D000981 | Antiprotozoal Agents |
| MeSH PA | D003049 | Coccidiostats |
| MeSH PA | D004791 | Enzyme Inhibitors |
| MeSH PA | D006131 | Growth Inhibitors |
| MeSH PA | D006133 | Growth Substances |
| MeSH PA | D011500 | Protein Synthesis Inhibitors |
Drug Use | Suggest Off label Use Form| |View source of the data|
None
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Chickens | Prevention of coccidiosis caused by Eimeria tenella | Indication |
| Chickens | Prevention of coccidiosis caused by E necatrix | Indication |
| Chickens | Prevention of coccidiosis caused by E acervulina | Indication |
| Chickens | Prevention of coccidiosis caused by E maxima | Indication |
| Chickens | Prevention of coccidiosis caused by E mivati | Indication |
| Chickens | Prevention of coccidiosis caused by E brunetti | Indication |
| Turkeys | Prevention of coccidiosis caused by Eimeria adenoeides | Indication |
| Turkeys | Prevention of coccidiosis caused by E meleagrimitis | Indication |
| Turkeys | Prevention of coccidiosis caused by E gallopavonis | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Stenorol | Huvepharma EOOD | 1 |
| Flavomycin / Stenorol | Huvepharma EOOD | 2 |
| BMD / Stenorol | Huvepharma EOOD | 2 |
| Stenorol Type A Medicated Article | Huvepharma EOOD | 1 |
| Flavomycin / Stenorol | Huvepharma EOOD | 2 |
| BMD / Stenorol | Huvepharma EOOD | 2 |
| Stenorol and LINCOMIX | Huvepharma EOOD | 2 |
Acid dissociation constants calculated using MoKa v3.0.0
None
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Proline--tRNA ligase, PfPRS, EC 6.1.1.15 | Unclassified | EC50 | 9.07 | IUPHAR |
External reference:
| ID | Source |
|---|---|
| HFG | PDB_CHEM_ID |
| CHEMBL1197091 | ChEMBL_ID |
| CHEMBL1199540 | ChEMBL_ID |
| C010176 | MESH_SUPPLEMENTAL_RECORD_UI |
| 10153 | IUPHAR_LIGAND_ID |
| DB04866 | DRUGBANK_ID |
| C0062095 | UMLSCUI |
| CHEMBL559362 | ChEMBL_ID |
| 3676 | INN_ID |
| 96157002 | SNOMEDCT_US |
| 64924-67-0 | SECONDARY_CAS_RN |
| D08034 | KEGG_DRUG |
| 456390 | PUBCHEM_CID |
| L31MM1385E | UNII |
Pharmaceutical products:
None